Superpage - Images
Superpage Topics
Abnormal uterine bleeding
Adenomatoid tumor
Adenomyosis / adenomyoma
Anatomy & histology
Arias-Stella reaction
Atypical polypoid adenomyoma
Carcinosarcoma (MMMT)
Clear cell carcinoma
Disordered proliferative
Endometrial carcinoma-general
Endometrial hyperplasia
Endometrial metaplasia
Endometrial polyp
Endometrial stromal nodule
Endometrioid carcinoma
Endometritis
Exogenous hormones
Grossing & features to report
High grade endometrial stromal sarcoma
Histology of specimens from gender affirming surgery in individuals assigned female at birth
Inflammatory myofibroblastic tumor
Intravenous and diffuse leiomyomatosis
Leiomyoma-general
Leiomyosarcoma
Low grade endometrial stromal sarcoma
Mesonephric-like adenocarcinoma (uterus / ovary)
POLE ultramutated endometrial carcinoma
Perivascular epithelioid cell tumor (PEComa)
Progestin therapy related changes
SMARCA4 deficient uterine sarcoma
Serous carcinoma
Smooth muscle tumors of uncertain malignant potential
Staging-carcinoma and carcinosarcoma
Undifferentiated / dedifferentiated carcinoma (endometrium / ovary)
Undifferentiated uterine sarcoma
Uterine tumors resembling ovarian sex cord tumors
Uterine tumors resembling ovarian sex cord tumorsAbnormal uterine bleeding
Microscopic (histologic) images
Adenomatoid tumor
Adenomyosis / adenomyoma
Gross images
Microscopic (histologic) images
Contributed by Ayse Ayhan, M.D., Ph.D.
Images hosted on other servers:
Anatomy & histology
Cytology images
- Refer to the following: Endometrial cells
Videos
Histology of benign cycling endometrium
Arias-Stella reaction
Atypical polypoid adenomyoma
Microscopic (histologic) images
Carcinosarcoma (MMMT)
Gross images
Microscopic (histologic) images
Clear cell carcinoma
Gross images
Microscopic (histologic) images
Contributed by Jutta Huvila, M.D.
Disordered proliferative
Endometrial carcinoma-general
Diagrams / tables
Gross images
- See endometrial carcinoma types
Cytology images
- See endometrial carcinoma types
Endometrial hyperplasia
Endometrial metaplasia
Microscopic (histologic) images
Contributed by Jessica L. Bentz, M.D.
Videos
Benign and premalignant lesions of the endometrium - Dr. Parra-Herran, from pathCast
Endometrial polyp
Gross images
Microscopic (histologic) images
Contributed by Monira Haque, M.D. and Yuri Tachibana, M.D.
Endometrial stromal nodule
Gross images
Endometrioid carcinoma
Gross images
Endometritis
Microscopic (histologic) images
Contributed by Stephanie L. Skala, M.D. and Yuri Tachibana, M.D.
Chronic endometritis
Xanthogranulomatous endometritis
Exogenous hormones
Microscopic (histologic) images
Grossing & features to report
Gross images
High grade endometrial stromal sarcoma
Gross images
Microscopic (histologic) images
Contributed by Elizabeth Kertowidjojo, M.D., Ph.D., M.P.H., Jennifer A. Bennett, M.D., Ondrej Ondič, M.D., Ph.D. and Ayse Ayhan, M.D., Ph.D.
Histology of specimens from gender affirming surgery in individuals assigned female at birth
Inflammatory myofibroblastic tumor
Radiology images
Microscopic (histologic) images
Intravenous and diffuse leiomyomatosis
Radiology images
Gross images
Contributed by Sabrina Croce, M.D., Ph.D.
Diffuse leiomyomatosis
Images hosted on other servers:
Microscopic (histologic) images
Videos
Intravenous leiomyomatosis
Leiomyoma-general
Diagrams / tables
Contributed by Sabrina Croce, M.D., Ph.D.
Table 2: differential diagnosis in uterine spindle cell smooth muscle lesions
| | | |
- | + | ≥ 10 | Leiomyosarcoma |
+ | + | ≥ 10 | |
+ | + | < 10 | |
- | - | > 15** | Smooth muscle tumor of uncertain malignant potential (STUMP) |
- | + | < 10 | |
+ | - | < 10 | |
- | - | ≥ 6 and ≤ 15** | Mitotically active leiomyoma |
* Mitoses/mm2 (mitoses/10 HPF of 0.55 mm in diameter) | |||
** > 15 or ≥ 15, cutoff value varies according to the references |
Table 3: differential diagnosis in uterine myxoid smooth muscle lesions
| | | |
Infiltrative borders | - | - | 1 or more of these criteria:
|
Atypia | - | - | |
Tumor cell necrosis | - | - | |
Mitoses* | - | 1 | |
* Mitoses/mm2 (mitoses/10 HPF of 0.55 mm in diameter) |
Table 4: differential diagnosis in uterine epithelioid smooth muscle lesions
| | | |
Atypia | - | - | 1 or more of these criteria:
|
Tumor cell necrosis | - | - | |
Mitoses* | < 2 | ≥ 2 and < 4 | |
* Mitoses/mm2 (mitoses/10 HPF of 0.55 mm in diameter) |
Gross images
Contributed by Sabrina Croce, M.D., Ph.D. and @Andrew_Fltv on Twitter
Compare with another remarkable case @kis_lorand
How about a new subtype of 'leiomyolipoma'?😀🤔😅
#grosspath #pathtwitter #gynpath #pathology #pathoutpic"
Contributed by @Andrew_Fltv on Twitter (see original post here)">
How about a new subtype of 'leiomyolipoma'?😀🤔😅
#grosspath #pathtwitter #gynpath #pathology #pathoutpic"
Contributed by @Andrew_Fltv on Twitter (see original post here)">
Lipoleiomyoma
Microscopic (histologic) images
Contributed by Sabrina Croce, M.D., Ph.D., Kristina Doytcheva, M.D., Jennifer A. Bennett, M.D. (Case #508) and @Andrew_Fltv on Twitter
Compare with another remarkable case @kis_lorand
How about a new subtype of 'leiomyolipoma'?😀🤔😅
#grosspath #pathtwitter #gynpath #pathology #pathoutpic"
Contributed by @Andrew_Fltv on Twitter (see original post here)"> Compare with another remarkable case @kis_lorand
How about a new subtype of 'leiomyolipoma'?😀🤔😅
#grosspath #pathtwitter #gynpath #pathology #pathoutpic"
Contributed by @Andrew_Fltv on Twitter (see original post here)"> Compare with another remarkable case @kis_lorand
How about a new subtype of 'leiomyolipoma'?😀🤔😅
#grosspath #pathtwitter #gynpath #pathology #pathoutpic"
Contributed by @Andrew_Fltv on Twitter (see original post here)">
How about a new subtype of 'leiomyolipoma'?😀🤔😅
#grosspath #pathtwitter #gynpath #pathology #pathoutpic"
Contributed by @Andrew_Fltv on Twitter (see original post here)"> Compare with another remarkable case @kis_lorand
How about a new subtype of 'leiomyolipoma'?😀🤔😅
#grosspath #pathtwitter #gynpath #pathology #pathoutpic"
Contributed by @Andrew_Fltv on Twitter (see original post here)"> Compare with another remarkable case @kis_lorand
How about a new subtype of 'leiomyolipoma'?😀🤔😅
#grosspath #pathtwitter #gynpath #pathology #pathoutpic"
Contributed by @Andrew_Fltv on Twitter (see original post here)">
Lipoleiomyoma
Leiomyosarcoma
Radiology images
Clinical images
Gross images
Microscopic (histologic) images
Contributed by Ashley Monsrud, M.D. and Paulette Mhawech-Fauceglia, M.D.
Videos
Review of uterine leiomyosarcoma
Low grade endometrial stromal sarcoma
Radiology images
Gross images
Contributed by Elizabeth Kertowidjojo, M.D., Ph.D., M.P.H. and Ayse Ayhan, M.D., Ph.D.
Images hosted on other servers:
Microscopic (histologic) images
Contributed by Elizabeth Kertowidjojo, M.D., Ph.D., M.P.H. and Ayse Ayhan, M.D., Ph.D.
Cytology images
Molecular / cytogenetics images
Videos
Endometrial stromal sarcoma
Uterine mesenchymal neoplasms
Mesonephric-like adenocarcinoma (uterus / ovary)
Microscopic (histologic) images
Contributed by Daniel Graham, M.D., Adele Wong, M.B., B.Ch., B.A.O. and Lucy Ma, M.D.
Videos
Mesonephric-like adenocarcinoma by Dr. Lewis Hassell
POLE ultramutated endometrial carcinoma
Diagrams / tables
Perivascular epithelioid cell tumor (PEComa)
Radiology images
Microscopic (histologic) images
Contributed by Jennifer Bennett, M.D.
Progestin therapy related changes
Diagrams / tables
Microscopic (histologic) images
Videos
PathCast lecture on benign endometrial pathology (May 2020)
SMARCA4 deficient uterine sarcoma
Serous carcinoma
Microscopic (histologic) images
Smooth muscle tumors of uncertain malignant potential
Staging-carcinoma and carcinosarcoma
Diagrams / tables
Table 1: Staging of endometrial carcinoma as per FIGO (2018 update) and AJCC 8th edition
FIGO (2018) | AJCC (2018) | Description |
I | T1 | Tumor confined to the uterus |
1A | T1a | Tumor confined to the endometrium or invades < 50% of the myometrial wall |
1B | T1b | Tumor invades > 50% of the myometrial wall |
II | T2 | Tumor infiltrates cervical stroma |
III | T3, N1 | Tumor extends outside the uterus |
IIIA | T3a | Tumor involves serosa or adnexa (direct extension or metastases) |
IIIB | T3b | Tumor involves vagina or parametria (direct extension or metastases) |
IIIC | N1 | Tumor with pelvic lymph node metastasis |
IIIC1 | N1 mi | Micrometastases in pelvic lymph nodes (> 0.2 mm or 200 cells but ≤ 2 mm) |
N1a | Macrometastases in pelvic lymph nodes (> 2 mm in size) | |
IIIC2 | N2 mi | Micrometastases in para-aortic lymph nodes (> 0.2 mm or 200 cells but ≤ 2 mm) |
N2a | Macrometastases in para-aortic lymph nodes (> 2 mm in size) | |
IV | T4, M1 | Tumor invades bladder or bowel mucosa or involves distant organs |
IVA | T4 | Tumor invades bladder mucosa or bowel mucosa |
IVB | M1 | Distant metastases (including intra-abdominal metastases and inguinal lymph nodes; excluding metastases to vagina, pelvic serosa or adnexa) |
N0i+ | Isolated tumor cells in regional lymph nodes* |
Table 2: 2023 FIGO staging of cancer of the endometrium
Stage | Description |
I | Confined to the uterine corpus and ovary |
IA | Disease limited to the endometrium or nonaggressive histological type (i.e., low grade endometroid, with invasion of < 50% of myometrium with no or focal lymphovascular space involvement [LVSI] or good prognosis disease) |
IA1 | Nonaggressive histological type limited to an endometrial polyp or confined to the endometrium |
IA2 | Nonaggressive histological types involving < 50% of the myometrium with no or focal LVSI |
IA3 | Low grade endometrioid carcinomas limited to the uterus and ovary |
IB | Nonaggressive histological types with invasion of ≥ 50% of the myometrium and with no or focal LVSI |
IC | Aggressive histological types limited to a polyp or confined to the endometrium |
II | Invasion of cervical stroma without extrauterine extension or with substantial LVSI or aggressive histological types with myometrial invasion |
IIA | Invasion of the cervical stroma of nonaggressive histological types |
IIB | Substantial LVSI of nonaggressive histological types |
IIC | Aggressive histological types with any myometrial involvement |
III | Local or regional spread of the tumor of any histological subtype |
IIIA | Invasion of uterine serosa, adnexa or both by direct extension or metastasis |
IIIA1 | Spread to ovary or fallopian tube (except when meeting stage IA3 criteria) |
IIIA2 | Involvement of uterine subserosa or spread through the uterine serosa |
IIIB | Metastasis or direct spread to the vagina or to the parametria or pelvic peritoneum |
IIIB1 | Metastasis or direct spread to the vagina or the parametria |
IIIB2 | Metastasis to the pelvic peritoneum |
IIIC | Metastasis to the pelvic or para-aortic lymph nodes or both |
IIIC1 | Metastasis to the pelvic lymph nodes |
IIIC1i | Micrometastasis |
IIIC1ii | Macrometastasis |
IIIC2 | Metastasis to para-aortic lymph nodes up to the renal vessels, with or without metastasis to the pelvic lymph nodes |
IIIC2i | Micrometastasis |
IIIC2ii | Macrometastasis |
IV | Spread to the bladder mucosa or intestinal mucosa or distance metastasis |
IVA | Invasion of the bladder mucosa or the intestinal / bowel mucosa |
IVB | Abdominal peritoneal metastasis beyond the pelvis |
IVC | Distant metastasis, including metastasis to any extra or intra-abdominal lymph nodes above the renal vessels, lungs, liver, brain or bone |
- Disease limited to low grade endometrioid carcinomas involving the endometrium and ovaries (stage IA3) must be distinguished from extensive spread of the endometrial carcinoma to the ovary (stage IIIA1), by the following criteria
- No more than superficial myometrial invasion is present (< 50%)
- Absence of extensive / substantial LVSI
- Absence of additional metastases
- The ovarian tumor is unilateral, limited to the ovary, without capsule invasion / rupture (equivalent to pT1a)
- LVSI as defined in WHO 2021: extensive / substantial, ≥ 5 vessels involved
- Aggressive histological types include serous carcinomas, clear cell carcinomas, mesonephric-like carcinomas, gastrointestinal type mucinous endometrial carcinoma, undifferentiated carcinomas and carcinosarcomas
- For endometrial endometrioid carcinomas, grade is based on the proportion of solid areas: low grade = grade 1 (≤ 5%) and grade 2 (6 - 50%); and high grade = grade 3 (> 50%)
- Nuclear atypia excessive for the grade raises the grade of a grade 1 or 2 tumor by one
- Nonaggressive histological types are composed of low grade (grade 1 and 2) endometrial endometrioid carcinomas
Table 3: 2023 FIGO endometrial cancer stage with molecular classification (for patients with early endometrial cancer [stages I and II after surgical staging])
Stage | Description |
IAmPOLEmut | POLEmut endometrial carcinoma, confined to the uterine corpus or with cervical extension, regardless of the degree of LVSI or histological type |
IICmp53abn | p53abn endometrial carcinoma confined to the uterine corpus with any myometrial invasion, with or without cervical invasion and regardless of the degree of LVSI or histological type |
Undifferentiated / dedifferentiated carcinoma (endometrium / ovary)
Undifferentiated uterine sarcoma
Uterine tumors resembling ovarian sex cord tumors
Uterine tumors resembling ovarian sex cord tumors
Diagrams / tables
N/A
Radiology images
N/A
Clinical images
N/A
Microscopic (histologic) images
Cytology images
N/A
Electron microscopy images
N/A
Molecular / cytogenetics images
N/A
Videos
N/A
Recent Uterus Pathology books
Find related Pathology books: breast, gynecologic